As Dr. REDDY’s (NSE: #DRREDDY)(NYSE: $RDY) continues to forge ahead with its strategic initiatives and dedication to their patients, it remains a compelling choice for investors seeking a strong performer in the pharmaceutical industry, poised for sustained growth and innovation.
In the dynamic world of pharmaceutical investments, DR. REDDY'S Laboratories (NSE: #DRREDDY) (NYSE: $RDY) stands out as a notable performer, surpassing #Pharma companies and #ETFs
Thread coming 🧵👇
For full post → @tradingview
https://t.co/nGAQqXGX66
3/4
Here are some fundamental metrics.
#DRREDDY P/E 19.65, EPS 283.95, Divided Yield 0.72%, beta 0.32.
All this outperform both ETF's and both companies.
🗝️ to success ➡️ Strategic initiatives, commitment to healthcare innovation and market expansion
Big..🚨
Tamil Nadu Technology Hub (iTNT Hub), which is India's First DeepTech Innovation Network has partnered with 🇬🇧Rolls Royce to boost Research and Technology empowering Tamil Nadu's MSMEs & Startups.. #TN#Startup
Starting a #startup update: 6 months later, the lab is open for business 🤓
The amount of steps between signing a lab lease to actually starting the science is wild but looking around today, I can’t believe how far we’ve come. PINCH ME!!
remember when analysts called Steve Jobs a fool about its visionary technologies $FB Visionaries are always growing while analysts only predict real facts after they occur not before.
#Technology#investors have a rare opportunity thanks to #ConfidentialComputing. Players like $HUB, $MSFT, $GOOG and many others are leading the sector.
https://t.co/2BTUIX6jHl
$HUB’s #shareholders and #optionholders voted to approve the previously announced #SPAC merger with $RNER and delisting from the $TASE. Hub-security-shareholders-approve-1-120600812.html
$MSFT earnings were ok. 11% rev growth (16% in cc) not bad, and runway is long. Azure +42% cc ($52bn run rate!) 😀, Dynamics 365 +32% cc impressive as SAAS slows. GM at 69.2%. Net income, FCF & EPS shrinking 🫤. Where’s the scale? Guide of $800m in incremental energy spend… 😬.